Binding Effect. This Amendment binds and is for the benefit of the successors and permitted assigns of each party.
Kaleido Biosciences, Inc. (KLDO) (CIK 0001751299)
Source: SEC EDGAR database • Date: May 4, 2021 • SIC: 2836 • CIK: 2836
BridgeBio Pharma, Inc. (BBIO) (CIK 0001743881)
Source: SEC EDGAR database • Date: February 25, 2021 • SIC: 2834 • CIK: 2834
Kaleido Biosciences, Inc. (KLDO) (CIK 0001751299)
Source: SEC EDGAR database • Date: June 18, 2020 • SIC: 2836 • CIK: 2836
Syndax Pharmaceuticals Inc (SNDX) (CIK 0001395937)
Source: SEC EDGAR database • Date: March 1, 2022 • SIC: 2834 • CIK: 2834
BridgeBio Pharma, Inc. (BBIO) (CIK 0001743881)
Source: SEC EDGAR database • Date: May 6, 2021 • SIC: 2834 • CIK: 2834
GERON CORP (GERN) (CIK 0000886744)
Source: SEC EDGAR database • Date: August 16, 2021 • SIC: 2834 • CIK: 2834
FUELCELL ENERGY INC (FCEL) (CIK 0000886128)
Source: SEC EDGAR database • Date: April 2, 2018 • SIC: 3690 • CIK: 3690